Cresta competitors

Thomas Marchand is a French entrepreneur based in Boston, graduated by ESSEC Business School (Paris). His first company in the private lesson industry was acquired in 2014 by the market leader. Thomas founded then BIOMODEX and served five years as the CEO & Chairman. This medical device company is developing 3d Printed patient-specific anatomical models designed to provide a pre-operative planning solution to physicians in the neurovascular and structural heart space. He raised $20M+ and built a 40 people team in Paris and Boston, including a manufacturing facility in Massachusetts. BIOMODEX counts Medtronic, Stryker, Boston Scientific, and J&J as customers. Thomas recently joined NIDO as the President and CEO, co-founded by Pedro Del Nido, Chairman of cardiovascular surgery at Boston Children Hospital and Professor at Harvard Medical School. NIDO is developing SEPIA, an innovative solution designed to improve epicardial ablation efficiency and, ultimately, cure Ventricular Tachycardia. NIDO is targeting a clearance by the FDA in 2022 and starting commercialization the same year. Thomas has been granted French American Entrepreneur of the year 2016 and is a regular guest at the entrepreneurial finance program at Babson College.

Louis Rosenberg is a technologist, prolific inventor, entrepreneur, writer, and currently the CEO of the artificial Intelligence company Unanimous AI. His doctoral work at Stanford University resulted in the virtual fixtures system for the US Air Force, the first immersive Augmented Reality system, built in 1992.